The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
Identity is verified. Human SYNE4 (C19orf46) encodes nesprin-4, also called KASH4/NESP4, matching UniProt Q8N205 and the supplied description. The literature consistently describes a 404-amino-acid nesprin-family protein with a C-terminal KASH domain; no similarly named protein from another organism was substituted in this analysis. The strongest functional annotation is that nesprin-4 is a non-enzymatic structural adaptor of the LINC complex. It resides in the outer nuclear membrane (ONM), connects through SUN proteins across the nuclear envelope, and recruits kinesin-1 on the cytoplasmic side. Its best-established physiological function is maintaining the basal position of nuclei in cochlear outer hair cells (OHCs), particularly when electromotility begins. Loss of this coupling causes nuclear displacement, OHC degeneration, and autosomal-recessive nonsyndromic hearing loss, DFNB76. (horn2013thelinccomplex pages 1-3, horn2013thelinccomplex pages 3-4, taiber2022anesprin4kinesin1cargo pages 9-11)
| Aspect | Best-supported finding | Evidence type | Key source/date |
|---|---|---|---|
| Identity | Human SYNE4 encodes the 404-aa protein nesprin-4, also called KASH4/NESP4; this matches UniProt Q8N205 and the nesprin/KASH-protein description. | Direct human genetic and protein-characterization evidence | Horn et al., February 2013 (horn2013thelinccomplex pages 1-3, horn2013thelinccomplex pages 3-4) |
| Architecture and topology | Nesprin-4 contains a spectrin repeat (reported residues 139–201), a kinesin-1-binding region (201–345), and a C-terminal KASH domain (346–404). Full-length protein localizes to the outer nuclear membrane; the KASH region spans that membrane and engages SUN proteins in the perinuclear space. | Direct localization/domain-mapping evidence; membrane-spanning LINC arrangement supported by established KASH topology | Horn et al., February 2013; Taiber et al., September 2022 (horn2013thelinccomplex pages 3-4, taiber2022anesprin4kinesin1cargo pages 1-2) |
| SUN partner | SUN1 supports nesprin-4 retention at the hair-cell nuclear envelope: nesprin-4 is lost from that site in Sun1-null mice, and Sun1-null animals show a similar nuclear-positioning and hearing phenotype. | Direct localization and genetic-phenocopy evidence; a specific physical SUN1–KASH bridge in hair cells is strongly supported but partly mechanistic inference | Horn et al., February 2013 (horn2013thelinccomplex pages 6-9, horn2013thelinccomplex pages 4-6) |
| Motor partner | Nesprin-4 binds conventional kinesin-1/KIF5B. A conserved four-residue kinesin-binding motif is required for functional rescue of nuclear positioning and hearing in vivo. | Direct interaction evidence in cultured cells plus in-vivo motif-disruption evidence | Horn et al., February 2013; Taiber et al., September 2022 (taiber2022anesprin4kinesin1cargo pages 9-11, horn2013thelinccomplex pages 6-9, taiber2022anesprin4kinesin1cargo pages 7-9) |
| Principal cell context | The best-defined physiological role is in cochlear sensory hair cells, especially outer hair cells (OHCs). Nesprin-4 is detected at hair-cell nuclear envelopes; Syne4 deficiency causes the early positioning and survival defect in OHCs rather than inner hair cells. | Direct mouse expression, localization, and loss-of-function evidence | Horn et al., February 2013; Taiber et al., September 2022 (taiber2022anesprin4kinesin1cargo pages 9-11, horn2013thelinccomplex pages 4-6) |
| Primary molecular function | Nesprin-4 is a structural LINC-complex motor adaptor, not an enzyme or transporter: it couples the outer nuclear membrane to plus-end-directed kinesin-1/microtubule machinery to maintain basal nuclear position. | Direct interaction and motif-rescue evidence supporting a microtubule-cargo model | Taiber et al., September 2022 (taiber2022anesprin4kinesin1cargo pages 9-11, taiber2022anesprin4kinesin1cargo pages 7-9, taiber2022anesprin4kinesin1cargo pages 1-2) |
| Relationship to electromotility | Nuclear displacement begins around P12–P14, near hearing onset and the emergence of OHC electromotility, despite earlier Syne4 expression. The proposed role is to stabilize the nucleus against electromotility-associated mechanical forces. | Timing is direct experimental evidence; resistance-to-force mechanism is a well-supported inference | Taiber et al., September 2022 (taiber2022anesprin4kinesin1cargo pages 9-11, taiber2022anesprin4kinesin1cargo pages 7-9) |
| Human loss-of-function phenotype | Homozygous truncating SYNE4 c.228delAT (p.W77Vfs*16) causes autosomal-recessive nonsyndromic deafness DFNB76, characterized in the founding families by progressive, predominantly high-frequency hearing loss. Truncated products fail to localize to the outer nuclear membrane. | Direct cosegregation, human phenotype, and mutant-localization evidence | Horn et al., February 2013 (horn2013thelinccomplex pages 1-3, horn2013thelinccomplex pages 3-4) |
| Mouse loss-of-function phenotype | Syne4-null OHC nuclei move from their normal basal position toward the apex, followed by basal-to-apical OHC degeneration and progressive hearing loss beginning around P15; inner-hair-cell loss occurs much later. | Direct knockout, histological, and auditory-physiology evidence | Horn et al., February 2013 (horn2013thelinccomplex pages 3-4, horn2013thelinccomplex pages 6-9, horn2013thelinccomplex pages 4-6) |
| Preclinical AAV rescue | Neonatal inner-ear delivery of AAV9-PHP.B–Syne4 restored basal nuclear position, OHC morphology and survival, ABR/DPOAE responses, and sound-associated behavior in Syne4-null mice; the best ABR thresholds reached approximately 15 dB at some frequencies. | Direct preclinical mouse intervention evidence | Taiber et al., December 2021 (taiber2021neonatalaavgene pages 10-11, brotto2024autosomalrecessivenonsyndromic pages 9-11, taiber2021neonatalaavgene pages 1-2) |
| Translational status | SYNE4 supplementation remains preclinical. Follow-up was limited to approximately 12 weeks, some auditory thresholds worsened over time, and durability and the human therapeutic window remain unresolved. A 2024 review listed human inner-ear AAV trials for OTOF but no SYNE4-targeted trial. | Direct study limitations plus 2024 field-review assessment | Taiber et al., December 2021; Brotto et al., February 2024 (taiber2021neonatalaavgene pages 10-11, taiber2021neonatalaavgene pages 1-2, brotto2024autosomalrecessivenonsyndromic pages 3-5, brotto2024autosomalrecessivenonsyndromic pages 11-12) |
Table: Compact evidence map for human SYNE4/Q8N205, separating direct findings from mechanistic inference across molecular architecture, nuclear positioning, deafness, and preclinical gene replacement.
The target is unambiguous within the retrieved literature:
Horn and colleagues directly identified human SYNE4 as the gene encoding nesprin-4/KASH4 and described a 404-residue product. Reported features include an N-terminal region, a spectrin repeat at approximately residues 139–201, a kinesin-associated region spanning residues 201–345, and a C-terminal KASH region at residues 346–404. These findings align with the supplied InterPro/Pfam KASH and SYNE4 annotations. (horn2013thelinccomplex pages 1-3, horn2013thelinccomplex pages 3-4)
The literature therefore supports the supplied identity, organism, family, and domain assignment. Although homologous proteins and functional analogues occur in mice, zebrafish, and C. elegans, they were used only as comparative evidence and were not treated as human SYNE4.
Nesprin-4 is an integral outer-nuclear-membrane protein. Its C-terminal KASH-containing segment traverses the ONM, leaving the short KASH terminus in the perinuclear space, where it associates with SUN-domain proteins in the inner nuclear membrane. Most of the protein, including its kinesin-binding region, faces the cytoplasm. This orientation lets nesprin-4 bridge cytoplasmic microtubule motors to SUN proteins and, indirectly, the nuclear lamina/nucleoskeleton. (horn2013thelinccomplex pages 3-4, taiber2022anesprin4kinesin1cargo pages 1-2)
Full-length human nesprin-4 localizes to the nuclear envelope, whereas severely truncated products associated with deafness—reported as approximately 93- and 51-residue products arising from frameshift or altered splicing—were diffusely cytoplasmic. Thus, loss of ONM targeting is a demonstrated molecular consequence of at least one pathogenic allele rather than merely an inferred effect of truncation. (horn2013thelinccomplex pages 3-4)
In the cochlea, mouse experiments detected nesprin-4 principally at the nuclear envelopes of inner and outer hair cells, with no detectable signal in supporting cells in the reported assay. SUN1 is present in the same hair-cell compartment; deletion of Sun1 removes nesprin-4 from the nuclear envelope, demonstrating that SUN1 is required for stable envelope localization in this context. (horn2013thelinccomplex pages 4-6)
The primary role of nesprin-4 is to form the cytoplasmic half of a specialized linker of nucleoskeleton and cytoskeleton (LINC) complex. SUN–KASH association spans the nuclear-envelope lumen, whereas the cytoplasmic portion of nesprin-4 engages kinesin-1. The resulting assembly mechanically couples the nucleus to microtubule-based force-generating machinery. (horn2013thelinccomplex pages 6-9, taiber2022anesprin4kinesin1cargo pages 1-2)
Accordingly, SYNE4 has no catalytic reaction or substrate specificity. “Cargo” is the more appropriate biochemical concept: nesprin-4 turns the nuclear envelope—and functionally the nucleus—into cargo for kinesin-1-mediated positioning.
Nesprin-4 binds conventional kinesin-1/KIF5B in heterologous-cell experiments. Later mechanistic work identified a conserved four-amino-acid kinesin-binding motif and tested its necessity in vivo. Wild-type Syne4 delivered by AAV prevented nuclear mislocalization, OHC death, and hearing loss, whereas motif-disrupted Syne4 failed to rescue and could phenocopy Syne4 deficiency in heterozygous mice, consistent with dominant-negative interference. (taiber2022anesprin4kinesin1cargo pages 9-11, horn2013thelinccomplex pages 6-9)
Comparable mutation of the conserved EWD motif in the C. elegans functional analogue UNC-83 preserved nuclear-envelope localization but disrupted kinesin-dependent nuclear migration. This evolutionary evidence separates motor recruitment from membrane targeting and strengthens the interpretation that the motif is a conserved functional kinesin interface. (taiber2022anesprin4kinesin1cargo pages 7-9)
A qualification is important: the investigators could not directly visualize robust kinesin-1 accumulation at the OHC nuclear envelope. The motor-adaptor model is nevertheless strongly supported by biochemical binding, motif conservation, and loss-of-rescue experiments, but the exact nanoscale motor organization and regulation in native OHCs remain unresolved. (taiber2022anesprin4kinesin1cargo pages 9-11)
The most precisely established biological process is basal nuclear positioning and anchorage in cochlear OHCs. OHCs are mechanically specialized cells whose somatic electromotility amplifies cochlear vibrations. In normal cells, the nucleus remains near the basal pole. In Syne4-null OHCs, nuclei progressively move toward the apical region, followed by OHC degeneration and hearing loss. (horn2013thelinccomplex pages 6-9, horn2013thelinccomplex pages 4-6)
The timing is mechanistically informative. Syne4 expression begins by approximately embryonic day 16, yet knockout OHCs show no detectable nuclear-position difference at P8. Displacement emerges around P12–P14, coinciding with hearing onset and development of OHC electromotility. Inner hair cells, which do not perform the same somatic electromotility, do not show the corresponding early positioning and survival defect. These observations support a model in which nesprin-4/kinesin-1 machinery stabilizes or positions the OHC nucleus against mechanical loads generated when electromotility begins. The timing and cell-type restriction are direct findings; the interpretation that electromotile force is the causal load remains a strong but incompletely proven inference. (taiber2022anesprin4kinesin1cargo pages 9-11, taiber2022anesprin4kinesin1cargo pages 7-9)
Electron microscopy did not reveal gross nuclear-envelope or subnuclear architectural disruption in knockout OHCs. It did identify increased spacing in lateral-wall submembrane cisternae, suggesting broader OHC structural damage, although whether this is primary or secondary to nuclear displacement is unknown. (taiber2022anesprin4kinesin1cargo pages 7-9)
SYNE4 participates principally in a mechanical cell-biological pathway, rather than a conventional ligand-driven signaling cascade:
Sun1-null mice reproduce the nuclear-positioning, OHC-degeneration, and hearing phenotypes and lose nesprin-4 from the hair-cell nuclear envelope. This genetic phenocopy and localization dependency strongly support a nesprin-4–SUN1 LINC assembly in hair cells, although they do not by themselves define the complete stoichiometry or exclude contributions from other SUN proteins. (kuwako2024diverserolesof pages 12-14, horn2013thelinccomplex pages 4-6)
The founding human report identified a homozygous SYNE4 c.228delAT, reported as p.W77Vfs*16, in two Iraqi-Jewish families with autosomal-recessive DFNB76. Hearing loss was progressive, predominantly high-frequency, noticed between birth and six years of age, and severe by adulthood. The variant cosegregated with disease, while four of 157 ancestry-matched controls were heterozygous, corresponding to a reported allele frequency of 0.013; it was absent from 105 controls of other origins. (horn2013thelinccomplex pages 1-3, horn2013thelinccomplex pages 3-4)
These data support loss of function through severe truncation and failure of nuclear-envelope localization. Human reports remain sparse, however. The available evidence indicates additional affected individuals or families in Israel, the United Kingdom, and Turkey, but does not support a robust population-wide prevalence estimate. SYNE4 should therefore be regarded as a rare, established deafness gene, not a common cause of hereditary hearing loss. (taiber2021neonatalaavgene pages 1-2)
The phenotype is generally described as nonsyndromic progressive sensorineural hearing loss. The founding mouse knockout had no major viability or overt behavioral abnormalities outside hearing, consistent with a comparatively tissue-restricted disease manifestation despite the fundamental cellular nature of LINC machinery. (horn2013thelinccomplex pages 3-4)
Syne4-null mice develop detectable auditory impairment by approximately P15 and broad-frequency hearing loss by P60. Reported ABR differences were statistically significant across tested frequencies—generally P<0.005, with P<0.05 at 36 kHz. OHC degeneration follows a basal-to-apical progression, consistent with early high-frequency involvement. OHC nuclei become apically displaced by about P14, preceding or accompanying degeneration. Inner hair cells remain initially intact, with loss reported much later, around P180. (horn2013thelinccomplex pages 3-4, horn2013thelinccomplex pages 6-9, horn2013thelinccomplex pages 4-6)
These findings establish a plausible causal chain:
SYNE4 loss → failed nuclear-envelope/microtubule coupling → OHC nuclear displacement → OHC degeneration → progressive hearing loss.
The ordering of nuclear displacement and cell death, phenocopy by Sun1 deletion, and rescue by wild-type Syne4 all support causality. The precise death pathway downstream of displacement has not been defined.
SYNE4 is relevant to molecular testing for recessive, progressive, predominantly high-frequency sensorineural hearing loss. Its inclusion in hereditary-hearing-loss panels is supported by cosegregating human loss-of-function variants and a closely matching mouse phenotype. Because published human cases are limited, variant interpretation should emphasize biallelic status, predicted effects on the KASH/topology or kinesin-binding regions, segregation, population frequency, and functional localization evidence.
The leading therapeutic application is preclinical inner-ear gene supplementation. Taiber and colleagues delivered AAV9-PHP.B–Syne4 through the posterior semicircular canal at P0–P1.5 in Syne4-null mice. Treatment restored basal nuclear position, OHC morphology and survival, ABR and DPOAE responses, and sound-associated behavior. The best treated animals reached ABR thresholds of approximately 15 dB at some frequencies. Behavioral groups comprised wild type (n=14), untreated knockout (n=16), knockout plus AAV-Syne4 (n=9), and knockout plus AAV-GFP (n=5). (taiber2021neonatalaavgene pages 10-11, taiber2021neonatalaavgene pages 1-2)
At 12 weeks, treated animals showed no substantial OHC loss or significant nuclear-position difference from wild type, and no general adverse effects on hearing, balance, or weight were observed in treated wild-type mice. Some auditory thresholds nevertheless worsened over time. Proposed explanations included incomplete transduction, transgene silencing, or immune responses to vector or transgene. Durability beyond approximately 12 weeks and the effective intervention window in humans remain unknown. (taiber2021neonatalaavgene pages 10-11)
A 2024 review of recessive nonsyndromic-deafness gene therapy identified the SYNE4 program as preclinical. The human inner-ear AAV trials it catalogued targeted OTOF, not SYNE4; thus, the retrieved literature provides no evidence of a SYNE4-targeted human clinical trial as of that review. (brotto2024autosomalrecessivenonsyndromic pages 3-5, brotto2024autosomalrecessivenonsyndromic pages 11-12)
Recent authoritative reviews have consolidated rather than substantially changed the functional model. A 2024 nervous-system LINC review concluded that human SYNE4 truncations cause hereditary deafness through loss of nuclear-envelope localization and emphasized the concordant mouse evidence: defective basal nuclear anchoring, OHC death, hearing loss, and rescue after AAV delivery. It also noted that the number of human SYNE4 reports remains limited. Published October 2024: https://doi.org/10.3390/ijms252111525. (kuwako2024diverserolesof pages 12-14)
A February 2024 review of AAV therapy for autosomal-recessive nonsyndromic deafness highlighted the near-complete physiological rescue in the Syne4-null mouse but placed it among preclinical programs, while clinical studies were concentrated on OTOF. Published February 2024: https://doi.org/10.3390/audiolres14020022. (brotto2024autosomalrecessivenonsyndromic pages 9-11, brotto2024autosomalrecessivenonsyndromic pages 3-5)
The key recent mechanistic advance immediately preceding this period was the 2022 demonstration that the conserved kinesin-binding motif is functionally required in vivo. This moved the field from a general LINC-association model to a more specific nesprin-4/kinesin-1 nuclear-cargo model. Published September 23, 2022: https://doi.org/10.3389/fcell.2022.974168. (taiber2022anesprin4kinesin1cargo pages 9-11, taiber2022anesprin4kinesin1cargo pages 1-2)
High-confidence annotations are: human identity as nesprin-4/KASH4; ONM localization; C-terminal KASH topology; kinesin-1 binding; participation with SUN1 in a hair-cell LINC complex; requirement for basal OHC nuclear positioning; and causal association of biallelic loss of function with DFNB76. These conclusions combine human genetics, protein localization, biochemical interaction, knockout phenotypes, genetic phenocopy, motif perturbation, and rescue experiments. (horn2013thelinccomplex pages 3-4, taiber2022anesprin4kinesin1cargo pages 9-11, horn2013thelinccomplex pages 4-6)
Important unresolved issues include:
The most defensible functional annotation for human SYNE4/Q8N205 is: an outer-nuclear-membrane KASH protein and kinesin-1 adaptor that forms a specialized LINC complex, mechanically coupling the nucleus to microtubules to maintain nuclear position—most critically in cochlear outer hair cells. It is not catalytic and has no molecular substrate. Its physiologically decisive “cargo” is the OHC nucleus. Loss of ONM targeting or motor coupling disrupts nuclear positioning, causes OHC degeneration, and produces DFNB76 progressive sensorineural deafness. AAV replacement has produced strong rescue in neonatal mice, but clinical implementation remains preclinical and human natural-history data remain limited. (taiber2022anesprin4kinesin1cargo pages 9-11, taiber2021neonatalaavgene pages 10-11, brotto2024autosomalrecessivenonsyndromic pages 11-12)
References
(horn2013thelinccomplex pages 1-3): Henning F. Horn, Zippora Brownstein, Danielle R. Lenz, Shaked Shivatzki, Amiel A. Dror, Orit Dagan-Rosenfeld, Lilach M. Friedman, Kyle J. Roux, Serguei Kozlov, Kuan-Teh Jeang, Moshe Frydman, Brian Burke, Colin L. Stewart, and Karen B. Avraham. The linc complex is essential for hearing. The Journal of clinical investigation, 123 2:740-50, Feb 2013. URL: https://doi.org/10.1172/jci66911, doi:10.1172/jci66911. This article has 209 citations.
(horn2013thelinccomplex pages 3-4): Henning F. Horn, Zippora Brownstein, Danielle R. Lenz, Shaked Shivatzki, Amiel A. Dror, Orit Dagan-Rosenfeld, Lilach M. Friedman, Kyle J. Roux, Serguei Kozlov, Kuan-Teh Jeang, Moshe Frydman, Brian Burke, Colin L. Stewart, and Karen B. Avraham. The linc complex is essential for hearing. The Journal of clinical investigation, 123 2:740-50, Feb 2013. URL: https://doi.org/10.1172/jci66911, doi:10.1172/jci66911. This article has 209 citations.
(taiber2022anesprin4kinesin1cargo pages 9-11): Shahar Taiber, Oren Gozlan, Roie Cohen, Leonardo R. Andrade, Ellen F. Gregory, Daniel A. Starr, Yehu Moran, Rebecca Hipp, Matthew W. Kelley, Uri Manor, David Sprinzak, and Karen B. Avraham. A nesprin-4/kinesin-1 cargo model for nuclear positioning in cochlear outer hair cells. Frontiers in Cell and Developmental Biology, Sep 2022. URL: https://doi.org/10.3389/fcell.2022.974168, doi:10.3389/fcell.2022.974168. This article has 19 citations.
(taiber2022anesprin4kinesin1cargo pages 1-2): Shahar Taiber, Oren Gozlan, Roie Cohen, Leonardo R. Andrade, Ellen F. Gregory, Daniel A. Starr, Yehu Moran, Rebecca Hipp, Matthew W. Kelley, Uri Manor, David Sprinzak, and Karen B. Avraham. A nesprin-4/kinesin-1 cargo model for nuclear positioning in cochlear outer hair cells. Frontiers in Cell and Developmental Biology, Sep 2022. URL: https://doi.org/10.3389/fcell.2022.974168, doi:10.3389/fcell.2022.974168. This article has 19 citations.
(horn2013thelinccomplex pages 6-9): Henning F. Horn, Zippora Brownstein, Danielle R. Lenz, Shaked Shivatzki, Amiel A. Dror, Orit Dagan-Rosenfeld, Lilach M. Friedman, Kyle J. Roux, Serguei Kozlov, Kuan-Teh Jeang, Moshe Frydman, Brian Burke, Colin L. Stewart, and Karen B. Avraham. The linc complex is essential for hearing. The Journal of clinical investigation, 123 2:740-50, Feb 2013. URL: https://doi.org/10.1172/jci66911, doi:10.1172/jci66911. This article has 209 citations.
(horn2013thelinccomplex pages 4-6): Henning F. Horn, Zippora Brownstein, Danielle R. Lenz, Shaked Shivatzki, Amiel A. Dror, Orit Dagan-Rosenfeld, Lilach M. Friedman, Kyle J. Roux, Serguei Kozlov, Kuan-Teh Jeang, Moshe Frydman, Brian Burke, Colin L. Stewart, and Karen B. Avraham. The linc complex is essential for hearing. The Journal of clinical investigation, 123 2:740-50, Feb 2013. URL: https://doi.org/10.1172/jci66911, doi:10.1172/jci66911. This article has 209 citations.
(taiber2022anesprin4kinesin1cargo pages 7-9): Shahar Taiber, Oren Gozlan, Roie Cohen, Leonardo R. Andrade, Ellen F. Gregory, Daniel A. Starr, Yehu Moran, Rebecca Hipp, Matthew W. Kelley, Uri Manor, David Sprinzak, and Karen B. Avraham. A nesprin-4/kinesin-1 cargo model for nuclear positioning in cochlear outer hair cells. Frontiers in Cell and Developmental Biology, Sep 2022. URL: https://doi.org/10.3389/fcell.2022.974168, doi:10.3389/fcell.2022.974168. This article has 19 citations.
(taiber2021neonatalaavgene pages 10-11): Shahar Taiber, Roie Cohen, Ofer Yizhar‐Barnea, David Sprinzak, Jeffrey R Holt, and Karen B Avraham. Neonatal aav gene therapy rescues hearing in a mouse model of syne4 deafness. EMBO Molecular Medicine, Dec 2021. URL: https://doi.org/10.15252/emmm.202013259, doi:10.15252/emmm.202013259. This article has 78 citations and is from a highest quality peer-reviewed journal.
(brotto2024autosomalrecessivenonsyndromic pages 9-11): Davide Brotto, Marco Greggio, Cosimo De Filippis, and Patrizia Trevisi. Autosomal recessive non-syndromic deafness: is aav gene therapy a real chance? Audiology Research, 14:239-253, Feb 2024. URL: https://doi.org/10.3390/audiolres14020022, doi:10.3390/audiolres14020022. This article has 9 citations.
(taiber2021neonatalaavgene pages 1-2): Shahar Taiber, Roie Cohen, Ofer Yizhar‐Barnea, David Sprinzak, Jeffrey R Holt, and Karen B Avraham. Neonatal aav gene therapy rescues hearing in a mouse model of syne4 deafness. EMBO Molecular Medicine, Dec 2021. URL: https://doi.org/10.15252/emmm.202013259, doi:10.15252/emmm.202013259. This article has 78 citations and is from a highest quality peer-reviewed journal.
(brotto2024autosomalrecessivenonsyndromic pages 3-5): Davide Brotto, Marco Greggio, Cosimo De Filippis, and Patrizia Trevisi. Autosomal recessive non-syndromic deafness: is aav gene therapy a real chance? Audiology Research, 14:239-253, Feb 2024. URL: https://doi.org/10.3390/audiolres14020022, doi:10.3390/audiolres14020022. This article has 9 citations.
(brotto2024autosomalrecessivenonsyndromic pages 11-12): Davide Brotto, Marco Greggio, Cosimo De Filippis, and Patrizia Trevisi. Autosomal recessive non-syndromic deafness: is aav gene therapy a real chance? Audiology Research, 14:239-253, Feb 2024. URL: https://doi.org/10.3390/audiolres14020022, doi:10.3390/audiolres14020022. This article has 9 citations.
(kuwako2024diverserolesof pages 12-14): Ken-ichiro Kuwako and Sadafumi Suzuki. Diverse roles of the linc complex in cellular function and disease in the nervous system. International Journal of Molecular Sciences, 25:11525, Oct 2024. URL: https://doi.org/10.3390/ijms252111525, doi:10.3390/ijms252111525. This article has 5 citations.